About this episode
On the outskirts of Marburg, a small college town in Germany, coronavirus vaccine manufacturer BioNTech has spent five frantic months renovating one of its factories to produce mRNA. Demand for the vaccine has been so massive that the Pfizer-BioNTech partnership can’t meet it with its existing facilities--hence the race to retrofit factories that weren't initially designed to support the vaccine. Naomi Kresge reports that success would mean being able to vaccinate about 375 million more people per year, and help bring the pandemic under control.
See omnystudio.com/listener for privacy information.
Get every episode summarized
Each time Prognosis: Misconception publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Prognosis: Misconception
Introducing: Levittown
Prognosis: Misconception
Listen Now: Beak Capitalism from Odd Lots
Prognosis: Misconception
Misconception: Great Expectations
Prognosis: Misconception
Misconception: Big Baby
Prognosis: Misconception